Coronavirus Vaccine Maker Pfizer Posts a Mixed Q4

1 min read

Pfizer (NYSE: PFE), now famous as the co-developer of the coronavirus vaccine BNT162b2, released its final quarterly results for fiscal 2020 on Tuesday.

These show that the company earned $11.68 billion in revenue, which was 12% higher than the same quarter of 2019. Of that, BNT162b2 — which received emergency use authorization from the FDA in December — was responsible for $154 million.

On the bottom line, Pfizer grew its non-GAAP (adjusted) net profit by 15% to nearly $2.37 billion, or $0.42 per share.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Sysco Corp (SYY) Q2 2021 Earnings Call Transcript

Next Story

Eaton Corporation PLC (ETN) Q4 2020 Earnings Call Transcript

Latest from Blog